7 June 2022 - Prescription drug spending in the US exceeded half a trillion dollars in 2020.
Spending is driven by high cost brand name drugs, for which manufacturers freely set prices after approval. Rising brand name drug prices often translate to payers restricting access, raising premiums, or imposing unaffordable out of pocket costs for patients.
We evaluated recent trends in prices for newly marketed brand name drugs.